Cell type-specific targeting with surface-engineered lentiviral vectors co-displaying OKT3 antibody and fusogenic molecule. [electronic resource]
- Pharmaceutical research Jun 2009
- 1432-45 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural